Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
PI ›
PIONEERING BIOSIMILARS
Trademark search for:
PIONEERING BIOSIMILARS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-09-02 — Application filed
2015-09-05 — Application filed
2015-09-08 — Application filed
2015-09-09 — Notice of pseudo mark e-mailed
2015-10-19 — Assigned to examiner
2015-10-22 — Approved for pub - principal register
2015-11-10 — Withdrawn from pub - og review query
2015-12-02 — Previous allowance count withdrawn
2015-12-04 — Examiners amendment -written
2015-12-04 — Examiners amendment e-mailed
2015-12-04 — Notification of examiners amendment e-mailed
2015-12-04 — Examiner's amendment entered
2015-12-04 — Approved for pub - principal register
2016-02-10 — Notification of notice of publication e-mailed
2016-03-01 — Published for opposition
2016-03-01 — Official gazette publication confirmation e-mailed
2016-04-26 — Noa e-mailed - sou required from applicant
2016-10-23 — Sou teas extension received
2016-10-23 — Sou extension 1 filed
2016-10-23 — Sou extension 1 granted
2016-10-25 — Notice of approval of extension request e-mailed
2017-04-14 — Sou teas extension received
2017-04-14 — Sou extension 2 filed
2017-04-14 — Sou extension 2 granted
2017-04-18 — Notice of approval of extension request e-mailed
2017-10-23 — Sou teas extension received
2017-10-23 — Sou extension 3 filed
2017-10-23 — Sou extension 3 granted
2017-10-25 — Notice of approval of extension request e-mailed
2018-04-19 — Sou teas extension received
2018-04-19 — Sou extension 4 filed
2018-04-19 — Sou extension 4 granted
2018-04-21 — Notice of approval of extension request e-mailed
2018-10-24 — Sou teas extension received
2018-10-24 — Sou extension 5 filed
2018-10-29 — Case assigned to intent to use paralegal
2018-10-29 — Sou extension 5 granted
2018-10-30 — Notice of approval of extension request e-mailed
2019-05-27 — Application abandoned
2019-05-27 — Final status recorded
2019-05-28 — Application abandoned
Owner Information
Novartis AG
Basel CH
Novartis AG
Basel CH
Correspondent
MAURY M. TEPPER, III Tepper & Eyster Pllc 3724 Benson Dr Raleigh, NC 27609-7321 UNITED STATES
Filing Details
Filing Date:
2015-09-02
Status Date:
2019-05-27
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.